

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 7.57172948 |
| 2 | cardiac myofibril assembly (GO:0055003) | 7.55360987 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.35147724 |
| 4 | myofibril assembly (GO:0030239) | 6.76177068 |
| 5 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.55195583 |
| 6 | actin-myosin filament sliding (GO:0033275) | 6.44839690 |
| 7 | muscle filament sliding (GO:0030049) | 6.44839690 |
| 8 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.89805901 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.85348188 |
| 10 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.76744209 |
| 11 | plasma membrane repair (GO:0001778) | 5.55855497 |
| 12 | response to muscle activity (GO:0014850) | 5.53866388 |
| 13 | actin-mediated cell contraction (GO:0070252) | 5.53859614 |
| 14 | tricarboxylic acid cycle (GO:0006099) | 5.46687172 |
| 15 | cardiac muscle contraction (GO:0060048) | 5.46383706 |
| 16 | regulation of skeletal muscle contraction (GO:0014819) | 5.38126307 |
| 17 | cardiac muscle cell development (GO:0055013) | 5.31985611 |
| 18 | regulation of relaxation of muscle (GO:1901077) | 5.29286362 |
| 19 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.10898003 |
| 20 | regulation of actin filament-based movement (GO:1903115) | 5.06935559 |
| 21 | actomyosin structure organization (GO:0031032) | 5.05916451 |
| 22 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.04539114 |
| 23 | cardiac cell development (GO:0055006) | 5.00577968 |
| 24 | carnitine shuttle (GO:0006853) | 4.99546106 |
| 25 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.79870409 |
| 26 | heart trabecula formation (GO:0060347) | 4.70662265 |
| 27 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.70656018 |
| 28 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.68483864 |
| 29 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.65211241 |
| 30 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.64485708 |
| 31 | regulation of sarcomere organization (GO:0060297) | 4.63468628 |
| 32 | regulation of cell communication by electrical coupling (GO:0010649) | 4.57879575 |
| 33 | adult heart development (GO:0007512) | 4.55974225 |
| 34 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.54798841 |
| 35 | cardiac muscle hypertrophy (GO:0003300) | 4.49629441 |
| 36 | striated muscle contraction (GO:0006941) | 4.48483738 |
| 37 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.48071688 |
| 38 | fatty acid transmembrane transport (GO:1902001) | 4.43520629 |
| 39 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.39624154 |
| 40 | muscle cell cellular homeostasis (GO:0046716) | 4.34639567 |
| 41 | striated muscle hypertrophy (GO:0014897) | 4.33995009 |
| 42 | regulation of striated muscle contraction (GO:0006942) | 4.30895998 |
| 43 | muscle tissue morphogenesis (GO:0060415) | 4.28393962 |
| 44 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.27940999 |
| 45 | actin filament-based movement (GO:0030048) | 4.23931229 |
| 46 | regulation of membrane repolarization (GO:0060306) | 4.20034306 |
| 47 | negative regulation of protein localization to cell surface (GO:2000009) | 4.14812029 |
| 48 | skeletal muscle fiber development (GO:0048741) | 4.13795204 |
| 49 | regulation of coenzyme metabolic process (GO:0051196) | 4.08307423 |
| 50 | regulation of cofactor metabolic process (GO:0051193) | 4.08307423 |
| 51 | myotube cell development (GO:0014904) | 4.02262470 |
| 52 | creatine metabolic process (GO:0006600) | 4.01044636 |
| 53 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.96531206 |
| 54 | regulation of sequestering of triglyceride (GO:0010889) | 3.88038580 |
| 55 | cell communication involved in cardiac conduction (GO:0086065) | 3.85371574 |
| 56 | heart contraction (GO:0060047) | 3.81425690 |
| 57 | heart process (GO:0003015) | 3.81425690 |
| 58 | regulation of the force of heart contraction (GO:0002026) | 3.79824434 |
| 59 | muscle hypertrophy (GO:0014896) | 3.77738789 |
| 60 | skeletal muscle tissue development (GO:0007519) | 3.76985758 |
| 61 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.73610119 |
| 62 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.71326518 |
| 63 | muscle fiber development (GO:0048747) | 3.66363745 |
| 64 | carnitine transmembrane transport (GO:1902603) | 3.66277337 |
| 65 | regulation of cardiac muscle contraction (GO:0055117) | 3.63866827 |
| 66 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.55558647 |
| 67 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.54041016 |
| 68 | relaxation of cardiac muscle (GO:0055119) | 3.53456116 |
| 69 | cell communication by electrical coupling (GO:0010644) | 3.46196646 |
| 70 | skeletal muscle adaptation (GO:0043501) | 3.43928590 |
| 71 | regulation of cardioblast differentiation (GO:0051890) | 3.41991911 |
| 72 | negative regulation of potassium ion transport (GO:0043267) | 3.39091542 |
| 73 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.36813399 |
| 74 | regulation of fatty acid oxidation (GO:0046320) | 3.33817245 |
| 75 | trabecula formation (GO:0060343) | 3.32929083 |
| 76 | regulation of sulfur metabolic process (GO:0042762) | 3.32498728 |
| 77 | carnitine transport (GO:0015879) | 3.30642179 |
| 78 | amino-acid betaine transport (GO:0015838) | 3.30642179 |
| 79 | muscle organ development (GO:0007517) | 3.30267925 |
| 80 | muscle structure development (GO:0061061) | 3.29401764 |
| 81 | muscle cell fate commitment (GO:0042693) | 3.29298335 |
| 82 | skeletal muscle contraction (GO:0003009) | 3.29175608 |
| 83 | * muscle contraction (GO:0006936) | 3.28502887 |
| 84 | regulation of heart rate (GO:0002027) | 3.28350127 |
| 85 | relaxation of muscle (GO:0090075) | 3.27745722 |
| 86 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.27715342 |
| 87 | cardiac muscle cell action potential (GO:0086001) | 3.27498181 |
| 88 | regulation of myoblast differentiation (GO:0045661) | 3.25830805 |
| 89 | muscle hypertrophy in response to stress (GO:0003299) | 3.25158580 |
| 90 | cardiac muscle adaptation (GO:0014887) | 3.25158580 |
| 91 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.25158580 |
| 92 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.19428606 |
| 93 | striated muscle cell development (GO:0055002) | 3.18710233 |
| 94 | NADH metabolic process (GO:0006734) | 3.10040457 |
| 95 | fatty acid beta-oxidation (GO:0006635) | 3.08600717 |
| 96 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.08196930 |
| 97 | * muscle system process (GO:0003012) | 3.07653054 |
| 98 | regulation of heart contraction (GO:0008016) | 3.06931137 |
| 99 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.06894065 |
| 100 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.06894065 |
| 101 | 2-oxoglutarate metabolic process (GO:0006103) | 3.06274008 |
| 102 | ventricular cardiac muscle cell development (GO:0055015) | 3.06054287 |
| 103 | positive regulation of myoblast differentiation (GO:0045663) | 3.04130020 |
| 104 | myoblast fusion (GO:0007520) | 2.96400789 |
| 105 | regulation of muscle contraction (GO:0006937) | 2.95910764 |
| 106 | regulation of ATPase activity (GO:0043462) | 2.95813617 |
| 107 | regulation of ATP catabolic process (GO:1903289) | 2.95813617 |
| 108 | striated muscle atrophy (GO:0014891) | 2.95711952 |
| 109 | positive regulation of cation channel activity (GO:2001259) | 2.91272446 |
| 110 | respiratory electron transport chain (GO:0022904) | 2.91173166 |
| 111 | striated muscle adaptation (GO:0014888) | 2.91117428 |
| 112 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.90798147 |
| 113 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.90798147 |
| 114 | striated muscle tissue development (GO:0014706) | 2.90789929 |
| 115 | response to inactivity (GO:0014854) | 2.90674802 |
| 116 | cardiac conduction (GO:0061337) | 2.90206702 |
| 117 | metanephric mesenchyme development (GO:0072075) | 2.89815692 |
| 118 | glycogen catabolic process (GO:0005980) | 2.87309239 |
| 119 | regulation of muscle system process (GO:0090257) | 2.86023573 |
| 120 | positive regulation of fatty acid oxidation (GO:0046321) | 2.83614545 |
| 121 | cGMP-mediated signaling (GO:0019934) | 2.83241193 |
| 122 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.83018948 |
| 123 | cell migration involved in heart development (GO:0060973) | 2.82166757 |
| 124 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.81667855 |
| 125 | electron transport chain (GO:0022900) | 2.81515798 |
| 126 | muscle cell development (GO:0055001) | 2.80993980 |
| 127 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.78600026 |
| 128 | muscle tissue development (GO:0060537) | 2.76123146 |
| 129 | extracellular fibril organization (GO:0043206) | 2.74046815 |
| 130 | myotube differentiation (GO:0014902) | 2.72327940 |
| 131 | response to epinephrine (GO:0071871) | 2.68729067 |
| 132 | glucan catabolic process (GO:0009251) | 2.66962610 |
| 133 | kidney mesenchyme development (GO:0072074) | 2.66871895 |
| 134 | relaxation of smooth muscle (GO:0044557) | 2.66281535 |
| 135 | muscle atrophy (GO:0014889) | 2.65841200 |
| 136 | regulation of skeletal muscle fiber development (GO:0048742) | 2.65423476 |
| 137 | positive regulation of myotube differentiation (GO:0010831) | 2.65230269 |
| 138 | muscle adaptation (GO:0043500) | 2.64954760 |
| 139 | glycogen biosynthetic process (GO:0005978) | 2.61588603 |
| 140 | glucan biosynthetic process (GO:0009250) | 2.61588603 |
| 141 | skeletal muscle tissue regeneration (GO:0043403) | 2.57501047 |
| 142 | negative regulation of muscle contraction (GO:0045932) | 2.57397457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.53607758 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.27505581 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.22753252 |
| 4 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.02686615 |
| 5 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.02686615 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.81730961 |
| 7 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.73494699 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.51689950 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.50169447 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.43407380 |
| 11 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.38722167 |
| 12 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.38680462 |
| 13 | * GBX2_23144817_ChIP-Seq_PC3_Human | 2.31079032 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.28071313 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.25592471 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.20850255 |
| 17 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.12579641 |
| 18 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.05901564 |
| 19 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.04136979 |
| 20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.84972937 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.82562261 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.73822752 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.66649211 |
| 24 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.62918404 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.60173998 |
| 26 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.57293667 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.57175193 |
| 28 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.54986357 |
| 29 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.50547614 |
| 30 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.46459413 |
| 31 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.46201961 |
| 32 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.46072647 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41813323 |
| 34 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.41543544 |
| 35 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.41353530 |
| 36 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.41353530 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.40950515 |
| 38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.38000128 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36399032 |
| 40 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.31475969 |
| 41 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31251223 |
| 42 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.29994272 |
| 43 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.29801056 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26950010 |
| 45 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.26623594 |
| 46 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24188898 |
| 47 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23502960 |
| 48 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23502960 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.21603646 |
| 50 | VDR_22108803_ChIP-Seq_LS180_Human | 1.20391933 |
| 51 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.19617937 |
| 52 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.19313498 |
| 53 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.19080481 |
| 54 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.16527798 |
| 55 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.15926209 |
| 56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15243887 |
| 57 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.14283724 |
| 58 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13676304 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12996929 |
| 60 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.12092568 |
| 61 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10263058 |
| 62 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09250053 |
| 63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09069098 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08439511 |
| 65 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08269885 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.07592423 |
| 67 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06099052 |
| 68 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05681940 |
| 69 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05639161 |
| 70 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.04213137 |
| 71 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02412372 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02375630 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01901348 |
| 74 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01713421 |
| 75 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.01361493 |
| 76 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01257490 |
| 77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00008408 |
| 78 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98153294 |
| 79 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.97819966 |
| 80 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.97649911 |
| 81 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97569623 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97135158 |
| 83 | P300_19829295_ChIP-Seq_ESCs_Human | 0.96652607 |
| 84 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.95400440 |
| 85 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.95217177 |
| 86 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.94361805 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94250108 |
| 88 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.93581357 |
| 89 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93428235 |
| 90 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92713089 |
| 91 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.92559003 |
| 92 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92286713 |
| 93 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.91780953 |
| 94 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.91780953 |
| 95 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91738204 |
| 96 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.91469584 |
| 97 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91029116 |
| 98 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.91013490 |
| 99 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90994302 |
| 100 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90927789 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90842893 |
| 102 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.90493030 |
| 103 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89927845 |
| 104 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89227622 |
| 105 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88565095 |
| 106 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.87638005 |
| 107 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87308561 |
| 108 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.87084091 |
| 109 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86080776 |
| 110 | TBL1_22424771_ChIP-Seq_293T_Human | 0.86069893 |
| 111 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85604391 |
| 112 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.85085881 |
| 113 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.84612295 |
| 114 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.84496695 |
| 115 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84133743 |
| 116 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83952274 |
| 117 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83895004 |
| 118 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83584948 |
| 119 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.83550305 |
| 120 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83260989 |
| 121 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.82747656 |
| 122 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81844883 |
| 123 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.80914843 |
| 124 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.80603010 |
| 125 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79990654 |
| 126 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.79571649 |
| 127 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.79532626 |
| 128 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.79506693 |
| 129 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.78065251 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77034896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.86682729 |
| 2 | MP0004084_abnormal_cardiac_muscle | 5.00418133 |
| 3 | MP0000751_myopathy | 4.89822699 |
| 4 | MP0003646_muscle_fatigue | 4.82543265 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.04210829 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.95523877 |
| 7 | MP0000749_muscle_degeneration | 3.73559294 |
| 8 | MP0005330_cardiomyopathy | 3.46689847 |
| 9 | MP0004087_abnormal_muscle_fiber | 2.97175146 |
| 10 | MP0002972_abnormal_cardiac_muscle | 2.84219029 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.82131039 |
| 12 | MP0004130_abnormal_muscle_cell | 2.80132578 |
| 13 | MP0000750_abnormal_muscle_regeneration | 2.71845021 |
| 14 | MP0008775_abnormal_heart_ventricle | 2.68021902 |
| 15 | MP0005620_abnormal_muscle_contractility | 2.66307915 |
| 16 | MP0004145_abnormal_muscle_electrophysio | 2.58603906 |
| 17 | MP0003137_abnormal_impulse_conducting | 2.48235978 |
| 18 | MP0002106_abnormal_muscle_physiology | 2.45531413 |
| 19 | MP0010630_abnormal_cardiac_muscle | 2.32886770 |
| 20 | MP0001544_abnormal_cardiovascular_syste | 2.31626384 |
| 21 | MP0005385_cardiovascular_system_phenoty | 2.31626384 |
| 22 | MP0004484_altered_response_of | 2.29918551 |
| 23 | MP0006138_congestive_heart_failure | 2.28773308 |
| 24 | MP0005369_muscle_phenotype | 2.11520896 |
| 25 | MP0002269_muscular_atrophy | 2.11198039 |
| 26 | MP0000747_muscle_weakness | 2.09788528 |
| 27 | MP0003950_abnormal_plasma_membrane | 2.08861150 |
| 28 | MP0003828_pulmonary_edema | 2.05959818 |
| 29 | MP0000759_abnormal_skeletal_muscle | 2.05651222 |
| 30 | MP0005275_abnormal_skin_tensile | 1.89923538 |
| 31 | MP0005666_abnormal_adipose_tissue | 1.85233618 |
| 32 | MP0004085_abnormal_heartbeat | 1.81382061 |
| 33 | MP0005670_abnormal_white_adipose | 1.76441713 |
| 34 | MP0003279_aneurysm | 1.73370760 |
| 35 | MP0004233_abnormal_muscle_weight | 1.66684032 |
| 36 | MP0005503_abnormal_tendon_morphology | 1.59496090 |
| 37 | MP0003221_abnormal_cardiomyocyte_apopto | 1.59300829 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.57418350 |
| 39 | MP0004272_abnormal_basement_membrane | 1.44121311 |
| 40 | MP0002108_abnormal_muscle_morphology | 1.43322372 |
| 41 | MP0005375_adipose_tissue_phenotype | 1.39026145 |
| 42 | MP0010368_abnormal_lymphatic_system | 1.34870659 |
| 43 | MP0004510_myositis | 1.33097704 |
| 44 | MP0002127_abnormal_cardiovascular_syste | 1.32460101 |
| 45 | MP0002332_abnormal_exercise_endurance | 1.26811069 |
| 46 | MP0005623_abnormal_meninges_morphology | 1.25644227 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.24620422 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.21217812 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 1.18547862 |
| 50 | MP0000733_abnormal_muscle_development | 1.15416628 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.09630041 |
| 52 | MP0000266_abnormal_heart_morphology | 1.06742300 |
| 53 | MP0000343_altered_response_to | 1.06386933 |
| 54 | MP0003136_yellow_coat_color | 1.03707374 |
| 55 | MP0001958_emphysema | 1.03072745 |
| 56 | MP0005165_increased_susceptibility_to | 1.01971143 |
| 57 | MP0003567_abnormal_fetal_cardiomyocyte | 1.01591389 |
| 58 | MP0009384_cardiac_valve_regurgitation | 0.98434943 |
| 59 | MP0002234_abnormal_pharynx_morphology | 0.95497796 |
| 60 | MP0003566_abnormal_cell_adhesion | 0.95483899 |
| 61 | MP0001661_extended_life_span | 0.92610833 |
| 62 | MP0000762_abnormal_tongue_morphology | 0.91168757 |
| 63 | MP0004270_analgesia | 0.89029134 |
| 64 | MP0002128_abnormal_blood_circulation | 0.87158430 |
| 65 | MP0002971_abnormal_brown_adipose | 0.86405004 |
| 66 | MP0001879_abnormal_lymphatic_vessel | 0.86061577 |
| 67 | MP0010030_abnormal_orbit_morphology | 0.85688583 |
| 68 | MP0000767_abnormal_smooth_muscle | 0.83191596 |
| 69 | MP0004134_abnormal_chest_morphology | 0.81153198 |
| 70 | MP0003879_abnormal_hair_cell | 0.79642786 |
| 71 | MP0001542_abnormal_bone_strength | 0.79250394 |
| 72 | MP0005451_abnormal_body_composition | 0.79052814 |
| 73 | MP0000230_abnormal_systemic_arterial | 0.78583213 |
| 74 | MP0002876_abnormal_thyroid_physiology | 0.73296226 |
| 75 | MP0002295_abnormal_pulmonary_circulatio | 0.72185749 |
| 76 | MP0005171_absent_coat_pigmentation | 0.71415481 |
| 77 | MP0001299_abnormal_eye_distance/ | 0.69080105 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.67480572 |
| 79 | MP0000372_irregular_coat_pigmentation | 0.67407101 |
| 80 | MP0001984_abnormal_olfaction | 0.67018157 |
| 81 | MP0010386_abnormal_urinary_bladder | 0.65485975 |
| 82 | MP0009780_abnormal_chondrocyte_physiolo | 0.59756523 |
| 83 | MP0003045_fibrosis | 0.58788384 |
| 84 | MP0000163_abnormal_cartilage_morphology | 0.53954601 |
| 85 | MP0002115_abnormal_skeleton_extremities | 0.53858711 |
| 86 | MP0008004_abnormal_stomach_pH | 0.53570940 |
| 87 | MP0006035_abnormal_mitochondrial_morpho | 0.53545654 |
| 88 | MP0005595_abnormal_vascular_smooth | 0.53061637 |
| 89 | MP0002925_abnormal_cardiovascular_devel | 0.52900065 |
| 90 | MP0001614_abnormal_blood_vessel | 0.52119122 |
| 91 | MP0005508_abnormal_skeleton_morphology | 0.50384523 |
| 92 | MP0009250_abnormal_appendicular_skeleto | 0.49963598 |
| 93 | MP0000534_abnormal_ureter_morphology | 0.49703042 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 0.48255669 |
| 95 | MP0002909_abnormal_adrenal_gland | 0.48096949 |
| 96 | MP0002249_abnormal_larynx_morphology | 0.47395264 |
| 97 | MP0005266_abnormal_metabolism | 0.47271078 |
| 98 | MP0005166_decreased_susceptibility_to | 0.46639856 |
| 99 | MP0005023_abnormal_wound_healing | 0.46456801 |
| 100 | MP0004043_abnormal_pH_regulation | 0.45712192 |
| 101 | MP0001502_abnormal_circadian_rhythm | 0.45482370 |
| 102 | MP0002896_abnormal_bone_mineralization | 0.44545761 |
| 103 | MP0009115_abnormal_fat_cell | 0.43934249 |
| 104 | MP0001270_distended_abdomen | 0.43779112 |
| 105 | MP0002114_abnormal_axial_skeleton | 0.43666912 |
| 106 | MP0002133_abnormal_respiratory_system | 0.43554033 |
| 107 | MP0005388_respiratory_system_phenotype | 0.43554033 |
| 108 | MP0002102_abnormal_ear_morphology | 0.43170366 |
| 109 | MP0005187_abnormal_penis_morphology | 0.43100521 |
| 110 | MP0002933_joint_inflammation | 0.40564210 |
| 111 | MP0003385_abnormal_body_wall | 0.40507930 |
| 112 | MP0001784_abnormal_fluid_regulation | 0.39411520 |
| 113 | MP0003091_abnormal_cell_migration | 0.39410402 |
| 114 | MP0002078_abnormal_glucose_homeostasis | 0.39161026 |
| 115 | MP0004147_increased_porphyrin_level | 0.36802050 |
| 116 | MP0003948_abnormal_gas_homeostasis | 0.36652866 |
| 117 | MP0005334_abnormal_fat_pad | 0.34939241 |
| 118 | MP0000920_abnormal_myelination | 0.32539765 |
| 119 | MP0008961_abnormal_basal_metabolism | 0.31708316 |
| 120 | MP0002060_abnormal_skin_morphology | 0.31309830 |
| 121 | MP0003935_abnormal_craniofacial_develop | 0.31179112 |
| 122 | MP0000428_abnormal_craniofacial_morphol | 0.31083329 |
| 123 | MP0005535_abnormal_body_temperature | 0.30536147 |
| 124 | MP0003690_abnormal_glial_cell | 0.30172711 |
| 125 | MP0002168_other_aberrant_phenotype | 0.30070650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.98167457 |
| 2 | Calf muscle hypertrophy (HP:0008981) | 5.99009786 |
| 3 | Ventricular tachycardia (HP:0004756) | 5.83053321 |
| 4 | Exercise-induced myalgia (HP:0003738) | 5.66562534 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.63085476 |
| 6 | Muscle fiber splitting (HP:0003555) | 5.62728746 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 5.55628188 |
| 8 | Atrial fibrillation (HP:0005110) | 5.33170629 |
| 9 | Abnormality of the calf musculature (HP:0001430) | 5.06936576 |
| 10 | Primary atrial arrhythmia (HP:0001692) | 4.95053847 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 4.87948693 |
| 12 | Lipoatrophy (HP:0100578) | 4.86557836 |
| 13 | Supraventricular tachycardia (HP:0004755) | 4.72660212 |
| 14 | Supraventricular arrhythmia (HP:0005115) | 4.66946422 |
| 15 | Myoglobinuria (HP:0002913) | 4.60111891 |
| 16 | Right ventricular cardiomyopathy (HP:0011663) | 4.51255420 |
| 17 | Subaortic stenosis (HP:0001682) | 4.48392122 |
| 18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.48392122 |
| 19 | Increased connective tissue (HP:0009025) | 4.20392734 |
| 20 | Type 1 muscle fiber predominance (HP:0003803) | 4.09363653 |
| 21 | Syncope (HP:0001279) | 4.04275221 |
| 22 | Ulnar deviation of the wrist (HP:0003049) | 4.03524188 |
| 23 | Myopathic facies (HP:0002058) | 4.01959775 |
| 24 | EMG: myopathic abnormalities (HP:0003458) | 3.98612858 |
| 25 | Dilated cardiomyopathy (HP:0001644) | 3.97058924 |
| 26 | Difficulty running (HP:0009046) | 3.96229669 |
| 27 | Bundle branch block (HP:0011710) | 3.93428896 |
| 28 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.79699252 |
| 29 | Prolonged QT interval (HP:0001657) | 3.76024196 |
| 30 | Asymmetric septal hypertrophy (HP:0001670) | 3.65872181 |
| 31 | Palpitations (HP:0001962) | 3.57158913 |
| 32 | Calcaneovalgus deformity (HP:0001848) | 3.56372360 |
| 33 | Ventricular arrhythmia (HP:0004308) | 3.53480668 |
| 34 | Rhabdomyolysis (HP:0003201) | 3.44924330 |
| 35 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.42292805 |
| 36 | Muscle fiber inclusion bodies (HP:0100299) | 3.41362485 |
| 37 | Myotonia (HP:0002486) | 3.37542459 |
| 38 | Heart block (HP:0012722) | 3.34359013 |
| 39 | Increased variability in muscle fiber diameter (HP:0003557) | 3.27694808 |
| 40 | Atrioventricular block (HP:0001678) | 3.25785164 |
| 41 | Aortic aneurysm (HP:0004942) | 3.25665982 |
| 42 | Absent phalangeal crease (HP:0006109) | 3.24733608 |
| 43 | Abnormal atrioventricular conduction (HP:0005150) | 3.22919586 |
| 44 | Deformed tarsal bones (HP:0008119) | 3.16852936 |
| 45 | Popliteal pterygium (HP:0009756) | 3.06919625 |
| 46 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.02806225 |
| 47 | Difficulty climbing stairs (HP:0003551) | 3.00922621 |
| 48 | Frequent falls (HP:0002359) | 3.00166008 |
| 49 | Broad metatarsal (HP:0001783) | 2.96638940 |
| 50 | Malignant hyperthermia (HP:0002047) | 2.95017269 |
| 51 | Ventricular fibrillation (HP:0001663) | 2.89662334 |
| 52 | Nemaline bodies (HP:0003798) | 2.84116268 |
| 53 | Muscle stiffness (HP:0003552) | 2.70710175 |
| 54 | Abnormal finger flexion creases (HP:0006143) | 2.67434494 |
| 55 | Weak cry (HP:0001612) | 2.66482595 |
| 56 | Aortic dissection (HP:0002647) | 2.58645574 |
| 57 | Abnormal EKG (HP:0003115) | 2.58178170 |
| 58 | Left ventricular hypertrophy (HP:0001712) | 2.58087690 |
| 59 | Neck muscle weakness (HP:0000467) | 2.55171655 |
| 60 | Fetal akinesia sequence (HP:0001989) | 2.53628952 |
| 61 | Bulbar palsy (HP:0001283) | 2.53547831 |
| 62 | Hypoplastic ischia (HP:0003175) | 2.52236857 |
| 63 | Ketoacidosis (HP:0001993) | 2.52176524 |
| 64 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.49000707 |
| 65 | Hypoglycemic coma (HP:0001325) | 2.43375898 |
| 66 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.41046307 |
| 67 | Hepatic necrosis (HP:0002605) | 2.39891823 |
| 68 | Scapular winging (HP:0003691) | 2.38440591 |
| 69 | Premature rupture of membranes (HP:0001788) | 2.37734142 |
| 70 | Spinal rigidity (HP:0003306) | 2.32320292 |
| 71 | Protrusio acetabuli (HP:0003179) | 2.32320079 |
| 72 | Fatigable weakness (HP:0003473) | 2.31168176 |
| 73 | Abnormality of the neuromuscular junction (HP:0003398) | 2.31168176 |
| 74 | Gowers sign (HP:0003391) | 2.28652485 |
| 75 | Abnormality of the ischium (HP:0003174) | 2.26998892 |
| 76 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.26837668 |
| 77 | Limited hip movement (HP:0008800) | 2.24632655 |
| 78 | Acute necrotizing encephalopathy (HP:0006965) | 2.22701050 |
| 79 | Distal lower limb muscle weakness (HP:0009053) | 2.21605277 |
| 80 | Slender build (HP:0001533) | 2.21549216 |
| 81 | Round ear (HP:0100830) | 2.18301019 |
| 82 | Palmoplantar keratoderma (HP:0000982) | 2.13870171 |
| 83 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.11752984 |
| 84 | Limb-girdle muscle atrophy (HP:0003797) | 2.11499457 |
| 85 | Ankle contracture (HP:0006466) | 2.10480408 |
| 86 | Pheochromocytoma (HP:0002666) | 2.07403636 |
| 87 | Areflexia of lower limbs (HP:0002522) | 2.07055339 |
| 88 | Muscular dystrophy (HP:0003560) | 2.05614956 |
| 89 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.05100689 |
| 90 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.04642475 |
| 91 | Generalized muscle weakness (HP:0003324) | 2.04625254 |
| 92 | Conjunctival hamartoma (HP:0100780) | 2.04261340 |
| 93 | Steppage gait (HP:0003376) | 2.03256160 |
| 94 | Distal lower limb amyotrophy (HP:0008944) | 1.99777099 |
| 95 | Facial diplegia (HP:0001349) | 1.97850841 |
| 96 | Distal arthrogryposis (HP:0005684) | 1.96447363 |
| 97 | Abnormality of the foot musculature (HP:0001436) | 1.96187518 |
| 98 | Dicarboxylic aciduria (HP:0003215) | 1.95610696 |
| 99 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.95610696 |
| 100 | Hepatocellular necrosis (HP:0001404) | 1.95562617 |
| 101 | Hyperkalemia (HP:0002153) | 1.95381993 |
| 102 | Acute encephalopathy (HP:0006846) | 1.93224328 |
| 103 | Progressive macrocephaly (HP:0004481) | 1.91715783 |
| 104 | Nonprogressive disorder (HP:0003680) | 1.90993239 |
| 105 | Hip contracture (HP:0003273) | 1.90668260 |
| 106 | Foot dorsiflexor weakness (HP:0009027) | 1.89367912 |
| 107 | Sudden cardiac death (HP:0001645) | 1.87765433 |
| 108 | Congestive heart failure (HP:0001635) | 1.85258999 |
| 109 | Vascular tortuosity (HP:0004948) | 1.85235312 |
| 110 | Type 2 muscle fiber atrophy (HP:0003554) | 1.85216751 |
| 111 | Aplasia of the musculature (HP:0100854) | 1.84762716 |
| 112 | Increased muscle lipid content (HP:0009058) | 1.84218978 |
| 113 | Waddling gait (HP:0002515) | 1.83612683 |
| 114 | Breech presentation (HP:0001623) | 1.83004231 |
| 115 | Metatarsus adductus (HP:0001840) | 1.82977814 |
| 116 | EMG: neuropathic changes (HP:0003445) | 1.82875596 |
| 117 | Pulmonary artery stenosis (HP:0004415) | 1.82594524 |
| 118 | Large for gestational age (HP:0001520) | 1.81493842 |
| 119 | Abnormality of alanine metabolism (HP:0010916) | 1.80200471 |
| 120 | Hyperalaninemia (HP:0003348) | 1.80200471 |
| 121 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.80200471 |
| 122 | Neuroendocrine neoplasm (HP:0100634) | 1.80135499 |
| 123 | Rimmed vacuoles (HP:0003805) | 1.79535779 |
| 124 | Abnormality of the calcaneus (HP:0008364) | 1.79399061 |
| 125 | Limb-girdle muscle weakness (HP:0003325) | 1.78933644 |
| 126 | Proximal amyotrophy (HP:0007126) | 1.78402771 |
| 127 | Testicular atrophy (HP:0000029) | 1.77289765 |
| 128 | Ketosis (HP:0001946) | 1.74558440 |
| 129 | Infantile muscular hypotonia (HP:0008947) | 1.72932003 |
| 130 | Hamartoma of the eye (HP:0010568) | 1.70377894 |
| 131 | Cerebral edema (HP:0002181) | 1.68415624 |
| 132 | Arterial tortuosity (HP:0005116) | 1.67189479 |
| 133 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.66925761 |
| 134 | Cerebral aneurysm (HP:0004944) | 1.63293481 |
| 135 | Soft skin (HP:0000977) | 1.56821293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.38699726 |
| 2 | OBSCN | 4.20653459 |
| 3 | PHKG1 | 3.56997494 |
| 4 | PHKG2 | 3.56997494 |
| 5 | LMTK2 | 3.40409276 |
| 6 | DMPK | 3.07581046 |
| 7 | MYLK | 3.03351176 |
| 8 | TRIB3 | 3.01845202 |
| 9 | PDK4 | 2.97139235 |
| 10 | PDK3 | 2.97139235 |
| 11 | PKN2 | 2.65326232 |
| 12 | TIE1 | 2.42701489 |
| 13 | MUSK | 2.31006399 |
| 14 | PIK3CA | 2.20361280 |
| 15 | BCKDK | 2.05533781 |
| 16 | FRK | 1.86209282 |
| 17 | PDK2 | 1.85627835 |
| 18 | PINK1 | 1.80651555 |
| 19 | STK24 | 1.77063530 |
| 20 | PDGFRA | 1.75882069 |
| 21 | NEK1 | 1.51997272 |
| 22 | PAK3 | 1.47084048 |
| 23 | STK39 | 1.39237312 |
| 24 | TRPM7 | 1.36442217 |
| 25 | PRKD1 | 1.32414301 |
| 26 | ILK | 1.30739381 |
| 27 | LATS1 | 1.21961598 |
| 28 | WNK4 | 1.21871702 |
| 29 | EPHB1 | 1.21707176 |
| 30 | INSRR | 1.20952231 |
| 31 | RIPK1 | 1.13543749 |
| 32 | ROCK1 | 1.10197848 |
| 33 | GRK7 | 1.10161252 |
| 34 | CAMK2D | 1.09248681 |
| 35 | MAP3K7 | 1.05166540 |
| 36 | STK38L | 1.02349919 |
| 37 | MARK3 | 0.98018693 |
| 38 | LATS2 | 0.97679859 |
| 39 | SIK1 | 0.96105955 |
| 40 | MAPK12 | 0.94283649 |
| 41 | PRKAA2 | 0.93992671 |
| 42 | CCNB1 | 0.90045411 |
| 43 | PRKD3 | 0.88911609 |
| 44 | BLK | 0.87842841 |
| 45 | ROCK2 | 0.85935199 |
| 46 | MARK1 | 0.85612841 |
| 47 | SGK2 | 0.85507676 |
| 48 | TGFBR2 | 0.84528035 |
| 49 | DDR2 | 0.83966006 |
| 50 | WNK1 | 0.83403043 |
| 51 | PKN1 | 0.82787225 |
| 52 | PRKAA1 | 0.81819103 |
| 53 | CDC42BPA | 0.80737189 |
| 54 | FGFR2 | 0.80593392 |
| 55 | ICK | 0.73568895 |
| 56 | CAMK1D | 0.72566240 |
| 57 | ZAK | 0.71300396 |
| 58 | MAPKAPK3 | 0.71259884 |
| 59 | SGK494 | 0.68282529 |
| 60 | SGK223 | 0.68282529 |
| 61 | NLK | 0.68064634 |
| 62 | NEK9 | 0.67419989 |
| 63 | RET | 0.62927326 |
| 64 | FLT3 | 0.62451641 |
| 65 | MET | 0.61310555 |
| 66 | PDGFRB | 0.61108025 |
| 67 | SGK3 | 0.60766766 |
| 68 | EPHB2 | 0.59731177 |
| 69 | ERBB3 | 0.58585164 |
| 70 | KSR2 | 0.58005765 |
| 71 | MAP3K9 | 0.57881058 |
| 72 | EPHA3 | 0.57660029 |
| 73 | CAMK2B | 0.56975168 |
| 74 | CAMK1G | 0.56464757 |
| 75 | PTK2B | 0.56378578 |
| 76 | CAMK2A | 0.56230427 |
| 77 | STK38 | 0.53379970 |
| 78 | PIK3CG | 0.53371369 |
| 79 | FER | 0.52491880 |
| 80 | PAK6 | 0.52126442 |
| 81 | CAMK4 | 0.50894157 |
| 82 | MOS | 0.50435921 |
| 83 | PRKCH | 0.50406706 |
| 84 | FGFR4 | 0.50361023 |
| 85 | PRKCE | 0.49519544 |
| 86 | PDPK1 | 0.48941047 |
| 87 | MELK | 0.48640567 |
| 88 | AKT3 | 0.46131538 |
| 89 | PRKG2 | 0.45331986 |
| 90 | PRKACB | 0.43688558 |
| 91 | BMPR1B | 0.43342926 |
| 92 | DAPK3 | 0.43338296 |
| 93 | MAP3K13 | 0.42568148 |
| 94 | MAP3K5 | 0.41774674 |
| 95 | STK4 | 0.40887710 |
| 96 | MAP3K1 | 0.39641080 |
| 97 | PRKD2 | 0.39599074 |
| 98 | PTK6 | 0.39098979 |
| 99 | LIMK1 | 0.39089796 |
| 100 | LRRK2 | 0.38546404 |
| 101 | CAMK2G | 0.38416542 |
| 102 | MAPK15 | 0.38378297 |
| 103 | MAPK4 | 0.38351700 |
| 104 | FGFR3 | 0.37331434 |
| 105 | KIT | 0.36863366 |
| 106 | CAMK1 | 0.36859927 |
| 107 | ADRBK1 | 0.34640417 |
| 108 | GSK3A | 0.32978269 |
| 109 | PTK2 | 0.32897800 |
| 110 | MTOR | 0.32826806 |
| 111 | MAP2K4 | 0.32788785 |
| 112 | PRKACA | 0.32787155 |
| 113 | PDK1 | 0.31631863 |
| 114 | MAP2K1 | 0.30827249 |
| 115 | PRKACG | 0.29754888 |
| 116 | PAK2 | 0.29023855 |
| 117 | GRK5 | 0.28928619 |
| 118 | FGFR1 | 0.27988593 |
| 119 | AKT2 | 0.27020698 |
| 120 | RPS6KB1 | 0.26646760 |
| 121 | MAP2K3 | 0.25920619 |
| 122 | RPS6KA3 | 0.24176351 |
| 123 | MAP3K6 | 0.24098606 |
| 124 | TGFBR1 | 0.23621196 |
| 125 | JAK1 | 0.23316892 |
| 126 | MAPK7 | 0.23259744 |
| 127 | STK3 | 0.22789531 |
| 128 | MAPKAPK5 | 0.21517557 |
| 129 | MARK2 | 0.20105999 |
| 130 | EEF2K | 0.20104294 |
| 131 | PRKG1 | 0.19453190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.29648420 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.67856204 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.59003109 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.58834763 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.52013031 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.43385290 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.89087495 |
| 8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.68415390 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.49591122 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47309710 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.27277314 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.08954867 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.01931224 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.80238763 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 1.76271823 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.74341824 |
| 17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.68042485 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.67881241 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67424595 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51829033 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.45611464 |
| 22 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.45251225 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41744881 |
| 24 | Focal adhesion_Homo sapiens_hsa04510 | 1.36917331 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35845964 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.35607105 |
| 27 | Huntingtons disease_Homo sapiens_hsa05016 | 1.32368777 |
| 28 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.31090227 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28992747 |
| 30 | Insulin resistance_Homo sapiens_hsa04931 | 1.23347483 |
| 31 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.16717552 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.16331174 |
| 33 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.15560722 |
| 34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.14501616 |
| 35 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.03265607 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.01638787 |
| 37 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.00804171 |
| 38 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.00338248 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89612440 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88577338 |
| 41 | Tight junction_Homo sapiens_hsa04530 | 0.87801083 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87355683 |
| 43 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.84350023 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82206721 |
| 45 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81320713 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.77020790 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77006181 |
| 48 | Lysine degradation_Homo sapiens_hsa00310 | 0.75990640 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75782061 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.75497541 |
| 51 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75018159 |
| 52 | Adherens junction_Homo sapiens_hsa04520 | 0.73323985 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 0.72473136 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71202251 |
| 55 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69046593 |
| 56 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68158487 |
| 57 | Mineral absorption_Homo sapiens_hsa04978 | 0.66899096 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65884522 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.63995790 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.63957782 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63162630 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63016239 |
| 63 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62914505 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61734966 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61662682 |
| 66 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59208847 |
| 67 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58901753 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58164204 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57961262 |
| 70 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.57371967 |
| 71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57244041 |
| 72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57211475 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55345731 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55248980 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53778336 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53655459 |
| 77 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52458510 |
| 78 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52167252 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51112789 |
| 80 | GABAergic synapse_Homo sapiens_hsa04727 | 0.50668092 |
| 81 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.50507692 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48624867 |
| 83 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48029907 |
| 84 | Bile secretion_Homo sapiens_hsa04976 | 0.47125917 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46132841 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.45427416 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44104690 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41459686 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.40728892 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40082208 |
| 91 | Long-term depression_Homo sapiens_hsa04730 | 0.40031632 |
| 92 | Phototransduction_Homo sapiens_hsa04744 | 0.39700464 |
| 93 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.39697958 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.39259440 |
| 95 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.39156979 |
| 96 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38391479 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36568806 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36175668 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35358974 |
| 100 | Insulin secretion_Homo sapiens_hsa04911 | 0.35328432 |
| 101 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34619307 |
| 102 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34511912 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.34000383 |
| 104 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.32498104 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32491433 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31075036 |
| 107 | Circadian entrainment_Homo sapiens_hsa04713 | 0.30328702 |
| 108 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30318326 |
| 109 | Gap junction_Homo sapiens_hsa04540 | 0.30020822 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26938583 |
| 111 | Melanogenesis_Homo sapiens_hsa04916 | 0.25508321 |
| 112 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.25038912 |
| 113 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.24915253 |
| 114 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.24491884 |
| 115 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.23822974 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23623479 |
| 117 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.23031674 |
| 118 | Melanoma_Homo sapiens_hsa05218 | 0.22941704 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22738406 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21950484 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20627905 |
| 122 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.19662495 |
| 123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19644357 |
| 124 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.19637444 |
| 125 | Axon guidance_Homo sapiens_hsa04360 | 0.18638021 |
| 126 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.18415607 |
| 127 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17837048 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.17661789 |
| 129 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.17291616 |
| 130 | Pathways in cancer_Homo sapiens_hsa05200 | 0.16930375 |
| 131 | Salivary secretion_Homo sapiens_hsa04970 | 0.15332745 |

